Mouse anti Human Cytochrome P450 3A7
X2048M
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman
TargetCYP3A7
Overview
- SupplierNordic-MUbio
- Product NameMouse anti Human Cytochrome P450 3A7
- Delivery Days Customer7
- Application Supplier NoteAntibody can be used for Western blotting (1-2 microg/ml) and immunohistochemistry on formalin-fixed, paraffin-embedded tissue sections (1-5 microg/ml). When used in conjunction with CYP3A5 (Cat. No. X2047M), can differentiate between the CYP3A family members, 3A5 and 3A7. Optimal concentration should be evaluated by serial dilutions.
- ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry
- Applications SupplierWestern Blotting;ELISA;Western Blotting;Immunohistochemistry
- Category SupplierPrimary antibodies
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDF19 P2 H2
- ConjugateUnconjugated
- Gene ID1551
- Target nameCYP3A7
- Target descriptioncytochrome P450 family 3 subfamily A member 7
- Target synonymsaryl hydrocarbon hydroxylase; CP37; CYPIIIA7; cytochrome P450 3A7; cytochrome P450, family 3, subfamily A, polypeptide 7; cytochrome P450, subfamily IIIA, polypeptide 7; cytochrome P450-HFLA; flavoprotein-linked monooxygenase; microsomal monooxygenase; P-450(HFL33); P-450111A7; P450-HFLA; P450HLp2; xenobiotic monooxygenase
- HostMouse
- IsotypeIgG1
- Protein IDQ9H241
- Protein NameCytochrome P450 3A7
- Scientific DescriptionCYP3A7; CYP450 3A7 (EC 1.14.14.1), CYPIIIA7, P450-HFLA
- Shelf life instructionSee expiration date on vial
- ReactivityHuman
- Reactivity SupplierHuman
- Reactivity Supplier NoteHybridoma produced by the fusion of splenocytes from BALB/c mice immunized with a synthetic peptide derived from the C-terminus of the human CYP3A7 protein and mouse myeloma Ag8563 cells.
- UNSPSC12352203
References
- 1. Kumarakasingham, M., et al. (2005). Cytochrome p450 profile of colorectal cancer: Identification of markers of prognosis. Clin. Cancer Res. 11(10);3758-3765. 2. Leeder, J.S., et al. (2005). Variability of CYP3A7 expression in human fetal liver. J. Pharmacol. Exp. Ther. 314(2);626-635. 3. Ogino, M., et al. (2002). Selective suppressions of human CYP3A forms, CYP3A5 and CYP3A7, by troglitazone in HepG2 cells. 17(1);42-46.